Search clinical trials for: Adapalene 0.1% Gel

Total 8580 results

Galderma R&D

Completed

Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne

Acne Vulgaris

United States
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

Recruiting

A First-in-Human Study of QY211 Gel in Adult Subjects

Atopic Dermatitis

China
Aleor Dermaceuticals Limited
Catawba Research, LLC

Completed

Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris

Acne Vulgaris

United States, Belize
Eisai Limited

Completed

A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Taro Pharmaceuticals USA

Completed

A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Aurobindo Pharma Ltd

Withdrawn

Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1%

Acne Vulgaris
Galderma R&D

Completed

Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Galderma R&D

Completed

Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance (ACCESS II)

Acne

United States, Canada, Puerto Rico
Mahidol University

Completed

An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne

Acne

Thailand
Patagonia Pharmaceuticals, LLC

Completed

A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis

Congenital Ichthyosis

United States
Galderma R&D

Completed

Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin

Skin Manifestations

United States
Galderma R&D

Completed

Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris.

Acne Vulgaris

Japan
Galderma R&D

Completed

Epiduo Pediatric Acne Study

Acne

United States, Canada
Multispecialty Aesthetic Clinical Research Organization
Galderma R&D

Unknown

A Pilot Study to Evaluate The Efficacy of Adapalene 0.3% for Use in the Prevention and Treatment of Senile Purpura

Senile Purpura

United States
Galderma R&D

Completed

Evaluate Effectiveness of Epiduo® Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes

P Acnes Colonization

United States
GlaxoSmithKline

Completed

Study to Investigate the Irritation Potential of GSK1940029 Gel

Acne Vulgaris

Australia
Galderma R&D

Completed

Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin

Skin Manifestations

United States
Galderma R&D

Completed

Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris

Acne Vulgaris

United States, Canada
Hoth Therapeutics, Inc.
Worldwide Clinical Trials

Recruiting

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors (CLEER)

Acneiform Eruption Due to Chemical | Xerosis Cutis | Paronychia

United States
Galderma R&D

Completed

Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne

Acne

United States
Galderma R&D

Completed

Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris

Acne

United States
Stiefel, a GSK Company

Completed

Study on Anti-inflammatory Effects of Topical R115866 Gel

Cutaneous Inflammation

Belgium
Galderma R&D

Completed

Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in Acne Vulgaris (FREE)

Acne

Canada
Galderma R&D

Completed

Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Taro Pharmaceuticals USA

Completed

Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Shaperon

Completed

A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon)

Atopic Dermatitis

Korea, Republic of
All India Institute of Medical Sciences, Bhubaneswar

Completed

Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris

Acne Vulgaris

India
Actavis Mid-Atlantic LLC

Completed

A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris

Acne Vulgaris

United States, Belize, India
Galderma R&D

Completed

A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients

Acne

Canada, France
University of Louisville

Withdrawn

Plantar Wart Treatment Using Adapalene Gel

Plantar Wart
Galderma R&D

Completed

Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne (EDeN)

Acne Vulgaris

United States, Mauritius, Singapore
Galderma Brasil Ltda.

Completed

A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of Photoaging (FOTEN)

Photoaging | Photodamage

Brazil
Allergan

Withdrawn

Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne

Acne Vulgaris
Padagis LLC

Completed

Comparative Safety and Bioequivalence of Two Treatments in the Treatment of Acne Vulgaris

Acne
Taro Pharmaceuticals USA

Completed

Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris

Acne Vulgaris
Allergan

Terminated

Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications

Acne Vulgaris

United States
Galderma R&D

Completed

Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage

Photoaging

United States
Actavis Mid-Atlantic LLC

Completed

Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel

Acne Vulgaris

India
Merete Haedersdal
Sebacia, Inc.

Completed

Multimodal Optical Imaging for Pretreatment Evaluation for Cutaneous Microparticle Delivery

Acne Vulgaris | Microparticles

Denmark
LEO Pharma

Completed

Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions

Actinic Keratosis

United States
Derm Research, PLLC

Completed

The Use of Oracea and Epiduo Forte in Severe Acne Patients

Acne

United States
Galderma R&D

Completed

Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris (TEAM)

Acne Vulgaris

Australia, Belgium, Brazil, France, Germany, Italy, Mexico, Poland, Sweden
Galderma R&D

Completed

Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Actavis Inc.

Completed

Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris

Acne

United States, Belize
Sun Pharmaceutical Industries Limited

Active, not recruiting

A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne

Acne Vulgaris

United States
Galderma R&D

Completed

Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris (ACCESS I)

Severe Acne Vulgaris

United States, Canada, Puerto Rico
Taro Pharmaceuticals USA

Completed

Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris

Acne Vulgaris
Bausch Health Americas, Inc.

Completed

Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face.

Acne Vulgaris

United States
TR Therapeutics

Completed

Efficacy Study of GLYC-101 to Evaluate Outcomes After Laser Ablation

Wounds

United States

3

Subscribe